The antihypertensive properties of single doses of furosemide were evaluated in 113 patients. Doses over 120 mg consistently produced a fall in arterial pressure whereas smaller doses did not. Thus 20 of 22 patients (90%) who received more than 120 mg had a 26 + 6% average reduction in mean arterial pressure. The hypotensive action began in 30 to 45 minutes, the nadir of the decrease occurred between 2 and 2X hours, and the hypotension usually lasted 10 to 12 hours. Repeated weekly doses of furosemide over a 2-month period in six patients were not associated with development of drug resistance. The antihypertensive properties of doses of furosemide of more than 120 mg seemed to be of about the same potency as ethacrynic acid. The antihypertensive effect of high doses of furosemide did not seem to be related to the diuretic effect or to the decrease in plasma volume.
SUMMARY
The antihypertensive properties of single doses of furosemide were evaluated in 113 patients. Doses over 120 mg consistently produced a fall in arterial pressure whereas smaller doses did not. Thus 20 of 22 patients (90%) who received more than 120 mg had a 26 + 6% average reduction in mean arterial pressure. The hypotensive action began in 30 to 45 minutes, the nadir of the decrease occurred between 2 and 2X hours, and the hypotension usually lasted 10 to 12 hours. Repeated weekly doses of furosemide over a 2-month period in six patients were not associated with development of drug resistance. The antihypertensive properties of doses of furosemide of more than 120 mg seemed to be of about the same potency as ethacrynic acid. The antihypertensive effect of high doses of furosemide did not seem to be related to the diuretic effect or to the decrease in plasma volume. These studies have demonstrated that doses of furosemide of more than 120 mg consistently decreased arterial pressure. The usefulness of this agent in the long-term management of hypertension remains to be determined.
Additional Indexing Words: Ethacrynic acid Plasma volume Sodium depletion PREVIOUS STUDIES from this laboratory have shown that furosemide is a potent, rapidly acting diuretic which is effective both parenterally and orally.1 Its potency and type of activity seemed to depend on the dosage used. Thus, the diuresis following doses of 40 to 60 mg was similar to that noted following thiazides, whereas the diuresis following doses of 100 mg and above was similar to that following ethacrynic acid. Furosemide was found to be particularly useful in the treatment of patients with severe congestive heart failure who had become refractory to both thiazides and organomercurial diuretics. After these patients had become free of edema, large doses of furosemide were frequently followed by significant reductions in arterial pressure. These observations suggested that furosemide might have antihypertensive properties separate from its diuretic effect which From would make it a unique saluretic agent. The present study was undertaken, therefore, to evaluate the antihypertensive properties of furosemide.
Methods
The patients were selected from the medical wards and hypertensive clinic of the District of Columbia General Hospital. One hundred thirteen hypertensive patients were studied; 40 were males and 73 were females. Each of the patients had objective evidence of vascular disease. Ophthalmoscopic examination revealed arteriovenous nicking in 104 patients and arteriovenous nicking plus retinopathy in 14 patients. The heart was enlarged in 96 patients. None of the patients was in congestive heart failure. There was electrocardiographic evidence of left ventricular hypertrophy in 92, bundle-branch block in 64, and subendocardial ischemia in six. In order to separate the diuretic from the antihypertensive effect, patients with any evidence of edema were excluded.
The effect of single administrations of furosemide was evaluated in 107 patients. Each of these patients had received antihypertensive therapy including diuretics, which was discontinued at least 7 days prior to administration of furosemide. Furosemide was supplied in 2-ml ampules 125 in a concentration of 10 mg/ml and was administered undiluted intravenously in Total blood volume = plasma volume I -(peripheral hematocrit x 0.91 x 0.96) and red cell volume from the formula: RCV= TBV -PV.
Cardiac output was determined in nine patients. Diuretics had been withheld from these patients for 7 days prior to and during the entire study. Serial relative changes in the cardiac output were determined by the dye-dilution method using Coomassie Bluet as indicator, a photoelectric earpiece, and a Mark II Cambridge Dye Recorder with a high resistance input circuit. They were expressed in arbitrary units derived from the reciprocal of the area under the recorded curve. 10 The total peripheral resistance was also expressed in arbitrary units from the formula: Total peripheral resistance equals mean arterial pressure divided by cardiac output. The arterial pressure was recorded by the auscultatory method. The mean arterial pressure was determined by the formula: Systolic 
Discussion
The data presented suggest that intravenous doses of furosemide over 120 mg consistently produce a fall in arterial pressure whereas smaller doses do not. Thus, only 21 of 62 patients who received less than 100 mg of furosemide had more than a 15% average fall in arterial pressure, whereas 20 of 22 who received more than 120 mg had more than a 15% average reduction.
The antihypertensive effect of high doses of furosemide did not seem to be secondary to or related to its diuretic effect. None of the patients studied showed any evidence of clinical edema. Although loss of weight, increase in urinary volume and urinary sodium and potassium, and a decrease in plasma volume consistently followed each administration of furosemide, no direct relation was noted between any of these parameters and the fall in arterial pressure. Thus, the average loss of weight following doses of furosemide above 120 mg was actually less than that observed after 40 mg of furosemide (table 1).
The urinary output and the urinary excretion of sodium were similar whether the dose of furosemide was under 100 mg or above (table   2) . Although the plasma volume was consistently decreased following furosemide, the average decrease in plasma volume was similar in those patients whose arterial pressure did not fall as in those whose arterial pressure did fall (table 3) .
The mechanism of the antihypertensive activity of high doses of furosemide remains unknown. The cardiac output 2 hours following furosemide was either unchanged or increased. The total peripheral resistance, however, was consistently decreased. It is interesting that although the plasma volume decreased whether the arterial pressure fell or not, the red cell volume fell only when the arterial pressure was reduced. The significance of the latter finding is not known. Current studies in our laboratory have shown that replacement of the plasma volume with dextran following furosemide has no effect on the arterial pressure. These data suggest that the antihypertensive effect of high doses of furosemide is separate from its effect on plasma volume.
In the six patients so studied, repeated injections of furosemide were not associated with the development of resistance at least during the 2-month period of observation. Although the fall in arterial pressure during the drug period exceeded that during the two placebo periods ( fig. 1) , the value of 
